Jun. 26 at 4:04 PM
$DARE Obviously hate how things are currently going. But realistically, it's not surprising:
- Only thing that'll move us up is Sildenafil or Ovaprene progress.
- Ovaprene gets a safety readout next month. Still probably at least 6 months to finish the study and get final data. Longer than that to get FDA approval.
- Sildenafil is a mess. They still don't have a Phase3 plan or
$30 million dollars to fund it. Maybe their plans to start selling it without Ph3 in Q4 will help, I dunno. Until they actually tell us about a meaningful partnership, it's a huge guessing game.
Otherwise, there's just not a reason this will magically go up until we get meaningful progress. Which looks to be awhile. Once that happens, lots of potential! Til then, giant meh.
